Stephen L. Lowe - Concepedia

Author

Stephen L. Lowe

Also Known As

Lowe, S.L., Lowe, Stephen L, S L Lowe, S Lowe, S. L. LOWE, S. L. Lowe, S. Lowe, S.L. Lowe, STEPHEN L. LOWE, Stephen L Lowe

105

Publications

4.2K

Citations

H-Index

120

Concepts

All Affiliations

Eli Lilly (United States)National University of Singapore University of North Dakota Guy's Hospital Eli Lilly (United Kingdom)

About

Stephen L. Lowe is an author at Eli Lilly (United States) specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	30	2.9K
2	Social Sciences	12	13	1.6K
3	Natural Sciences	5	5	556
4	Health Sciences	4	4	240
5	Anesthesia	2	2	27

Stephen L. Lowe

Publications

Citations

H-Index

Page 1

	Year	Citations
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Sandeep T. Patil, Lu Zhang, Ferenc Martényi, Nature Medicine PsychiatryPsychotic DisorderMedicinePsychotropic MedicationMglu2/3 Receptors	2007	1K
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor Patrick C. May, Robert A. Dean, Stephen L. Lowe, Journal of Neuroscience Robust Central ReductionAmyloid-β PeptideNeurochemical BiomarkersPeptide ScienceAmyloid Precursor Protein	2011	365
Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease Andrew Procter, Alan M. Palmer, Paul T. Francis, Journal of Neurochemistry	1988	197
The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans Patrick C. May, Brian A. Willis, Stephen L. Lowe, Journal of Neuroscience Amyloid βNeurodegenerative DiseasesAmyloid LoweringAlzheimer's DiseaseKey Protease	2015	195
Topographical distribution of neurochemical changes in Alzheimer's disease Andrew Procter, Stephen L. Lowe, Alan M. Palmer, Journal of the Neurological Sciences Topographical DistributionAlzheimer's DiseaseDementiaNeurologyNeuroscience	1988	136
GAMMA-AMINOBUTYRIC ACID CONCENTRATION IN BRAIN TISSUE AT TWO STAGES OF ALZHEIMER'S DISEASE Stephen L. Lowe, Paul T. Francis, Andrew Procter, Brain Neurochemical BiomarkersSocial SciencesGaba ConcentrationAlzheimer's DiseaseNeurology	1988	132
Reduced Glycine Stimulation of [<sup>3</sup>H]MK‐801 Binding in Alzheimer's Disease Andrew Procter, E. H. F. Wjong, Gary C. Stratmann, Journal of Neurochemistry	1989	115
Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease Stephen L. Lowe, Brian A. Willis, Anne Hawdon, Alzheimer s & Dementia Translational Research & Clinical Interventions	2021	114
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging Stephen L. Lowe, Cynthia Evans, Sergey Shcherbinin, The Journal of Prevention of Alzheimer s Disease	2021	100
Serum electrolyte changes after marathon running. Leslie I. Rose, David Carroll, Stephen L. Lowe, Journal of Applied Physiology Electrolyte DisorderExercise PhysiologyPhysiologyElectrolyte DisturbanceClinical Chemistry	1970	98

Page 1